TEVA PHARMACEUTICAL INDUSTRIES LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 139122
 
  
 
C07D HETEROCYCLIC COMPOUNDS 30132
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 27111
 
  
 
2902 DEVICES AND EQUIPMENT FOR ACCIDENT PREVENTION AND FOR RESCUE, NOT ELSEWHERE SPECIFIED275
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2075
 
  
 
A61J CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 1218
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9197
 
  
 
C07K PEPTIDES 8128
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 6148
 
  
 
B65D CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 692

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,275 TREATMENT OF OCULAR INFLAMMATORY DISEASES USING LAQUINIMODNov 17, 17Mar 15, 18[A61K]
2018/0064,702 TREATMENT OF PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS WITH LAQUINIMODNov 13, 17Mar 08, 18[A61K]
2018/0050,031 Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl FumarateNov 03, 17Feb 22, 18[A61K]
2018/0042,913 USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSIONOct 26, 17Feb 15, 18[A61K]
2018/0042,916 TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMODSep 11, 17Feb 15, 18[A61K]
2018/0036,302 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND A STATINDec 09, 15Feb 08, 18[A61K]
2018/0036,363 PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCTOct 19, 17Feb 08, 18[A61K]
2018/0015,094 TREATMENT OF CROHN'S DISEASE WITH DELAYED-RELEASE 6-MERCAPTOPURINESep 28, 17Jan 18, 18[A61K]
2018/0000,812 TREATMENT OF CROHN'S DISEASE WITH LAQUINIMODSep 13, 17Jan 04, 18[A61K]
2018/0000,884 PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCTSep 18, 17Jan 04, 18[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9827374 Re-useable injector device for syringeOct 08, 13Nov 28, 17[A61M]
9763993 Process for manufacturing glatiramer acetate productSep 21, 15Sep 19, 17[A61K]
9707264 Process for manufacturing glatiramer acetate productSep 21, 15Jul 18, 17[A61K]
9702007 Genetic markers predictive of response to glatiramer acetateOct 21, 14Jul 11, 17[A61K, C12Q]
9687522 Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosisApr 30, 14Jun 27, 17[A61K, G01N]
9662322 Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability statusNov 19, 15May 30, 17[A61J, A61K, A61B, A61P]
9625473 Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetateMay 07, 15Apr 18, 17[A61K, G01N, C07K]
9626481 Dose counter and recording methodJun 24, 13Apr 18, 17[G06F, A61M]
9617596 Biomarkers predictive for clinical response for glatiramer acetateOct 09, 13Apr 11, 17[C12Q]
D783804 Respiratory apparatusApr 07, 14Apr 11, 17[2902]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2018/0002,753 GENETIC MARKERS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATEAbandonedJan 19, 17Jan 04, 18[A61K, C12Q]
2017/0354,651 Treatment Of Neurodegenerative Diseases With Combination Of Laquinimod And FingolimodAbandonedAug 04, 17Dec 14, 17[A61J, A61K, B65D]
2017/0333,418 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FINGOLIMODAbandonedJul 31, 17Nov 23, 17[A61J, A61K]
2017/0333,420 TREATMENT OF OCULAR INFLAMMATORY DISEASES USING LAQUINIMODAbandonedAug 07, 17Nov 23, 17[A61K]
2017/0327,464 CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOFAbandonedAug 01, 17Nov 16, 17[C07D]
2017/0319,570 Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl FumarateAbandonedJul 27, 17Nov 09, 17[A61K]
2017/0312,331 PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCTAbandonedSep 21, 15Nov 02, 17[A61K]
2017/0312,264 USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSIONAbandonedJul 18, 17Nov 02, 17[A61K]
2017/0304,253 Laquinimod Combination Therapy For Treatment Of Multiple SclerosisAbandonedJul 06, 17Oct 26, 17[A61K]
2017/0290,822 USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNF THERAPYAbandonedJun 26, 17Oct 12, 17[A61K, C07D]
2017/0266,179 Treatment of Glaucoma Using LaquinimodAbandonedJun 01, 17Sep 21, 17[A61J, A61K, B65D]
2017/0266,180 TREATMENT OF CROHN'S DISEASE WITH LAQUINIMODAbandonedJun 05, 17Sep 21, 17[A61K]
2017/0258,780 TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMODAbandonedMay 30, 17Sep 14, 17[A61K, C07D]
2017/0239,234 TREATMENT OF BDNF-RELATED DISORDERS USING LAQUINIMODAbandonedFeb 07, 17Aug 24, 17[A61K]
2017/0231,971 TREATMENT OF OCULAR INFLAMMATORY DISEASES USING LAQUINIMODAbandonedApr 28, 17Aug 17, 17[A61K]
2017/0224,674 Treatment Of Neurodegenerative Diseases With Combination Of Laquinimod And FingolimodAbandonedApr 21, 17Aug 10, 17[A61J, A61K, B65D]
2017/0224,675 Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl FumarateAbandonedApr 24, 17Aug 10, 17[A61K]
2017/0209,427 USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSIONAbandonedApr 05, 17Jul 27, 17[A61K]
2017/0196,930 PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCTAbandonedMar 28, 17Jul 13, 17[A61K]
2017/0143,824 RITUXIMAB INDUCTION THERAPY FOLLOWED BY GLATIRAMER ACETATE THERAPYAbandonedFeb 06, 17May 25, 17[A61J, A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.